Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link

Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.

Volume 32, Number 9—September 2026

Dispatch

Serologic Evidence of Hantavirus Exposure in Humans, Italy, 2004–2018

Giulia Faolotto, Anishia WasbergComments to Author , Rommel Iheozor-Ejiofor, Essi M. Korhonen, Rosalba Minisini, Tarja Sironen, Ruut Joensuu, Jiaxin Ling, Åke Lundkvist, Olli Vapalahti, Eili Huhtamo, and Paolo Ravanini
Author affiliation: Maggiore della Carità University Hospital, Novara, Italy (G. Faolotto, P. Ravanini); Uppsala University, Uppsala, Sweden (A. Wasberg, J. Ling, Å. Lundkvis); University of Helsinki, Helsinki, Finland (R. Iheozor-Ejiofor, E.M. Korhonen, T. Sironen, R. Joensuu, O. Vapalahti, E. Huhtamo); University of Eastern Piedmont, Novara (R. Minisini); University of Helsinki and Helsinki University Hospital, HUSLAB, Helsinki (O. Vapalahti)

Main Article

Table 1

Antibody screening results determined by immunofluorescence assay in study of serologic evidence of hantavirus exposure in humans, Italy, 2004–2018

Classification/patient group description Sampling year No. (%) patients
Total Hantavirus IgG positive
LCMV IgG positive
PUUV DOBV Combined
Alcohol abuse
2013–2016 (mostly 2013)
28 (7.55)
2 (7.14)
1 (3.57)
3 (10.71)
0
Liver diseases
2004, 2009, 2012 (mostly 2012)
177 (47.71)
5 (2.82)
11 (6.21)
16 (9.04)
4 (1.69)
HCV infections
2018
30 (8.09)
0
0
0
1 (3.33)
Renal diseases
2006, 2007, 2018
110 (29.65)
3 (2.72)
3 (2.72)
6 (5.45)
5 (4.55)
Oral anticoagulant treatment
2007
26 (7)
1 (3.85)
1 (3.85)
2 (7.69)
0
Total 371 (100) 11 (2.96) 16 (4.31) 27 (7.28) 10 (2.70)

*DOBV, Dobrava-Belgrade virus; HCV, hepatitis C virus; LCMV, lymphocytic choriomeningitis virus; PUUV, Puumala virus.

Main Article

Page created: July 09, 2026
Page updated: July 09, 2026
Page reviewed: July 09, 2026
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external